Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
Background and objective Bevacizumab is a recombinant, humanised, monoclonal antibody against the vascular endothelial growth factor receptor (VEGFR), the aim of this meta-analysis is to evaluate the clinical efficacy and safety of bevacizumab combined with chemotherapy for non-small cell lung cance...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Chinês |
| Publié: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2013-02-01
|
| Collection: | Chinese Journal of Lung Cancer |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.05 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|